Health
Covid-19 vaccine: A shot at redemption for J&J? – Yahoo Finance Australia
US health care giant Johnson & Johnson, beset by recent scandals over talcum powder and the opioid crisis, is poised for a reputational lift with its…
US health care giant Johnson & Johnson, beset by recent scandals over talcum powder and the opioid crisis, is poised for a reputational lift with its pathbreaking coronavirus vaccine.
J&J, which has vowed to sell the vaccine at cost, won approval Thursday from the European Union for its Covid-19 jab after receiving the green light earlier from regulators in the United States, Canada and South Africa.
The J&J inoculation is the first approved by health authorities to require just one shot, the latest…
-
Noosa News22 hours agoBrisbane man charged with arson and attempted murder after violent house fire at Wynnum West
-
Business16 hours ago3 perfect ASX ETFs for beginners
-
Noosa News21 hours agoAI a ‘strategic necessity’ law lecturer says – Proctor
-
Business19 hours agoDown 53% in a year, are Domino’s shares now on sale?